Stock EMMLD OKYO PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Insiders OKYO Pharma Limited

Equities

EMMLD

GG00BMFG5F62

Market Closed - Nasdaq
Other stock markets
 21:30:00 13/06/2024 BST 		5-day change 1st Jan Change
1.36 USD +3.05% Intraday chart for OKYO Pharma Limited +1.50% -23.16%
03-22 H.C. Wainwright Adjusts Price Target on OKYO Pharma to $7 From $6, Maintains Buy Rating MT
03-22 OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain Relief in its First-in-Human Phase 2 Trial of OK-101 CI

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
OKYO Pharma Limited Announces Appointment of Scientific Advisory Board
CI
OKYO Pharma Announces Appointment of William A. Clementi as Chief Operating Officer, Effective September 1, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EMMLD Stock
  4. News OKYO Pharma Limited
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW